The rising interest in GLP-1 agonists for diabetes has sparked a debate about delivery routes : skin-applied devices versus tablets . Typically, GLP-1 drugs were solely available in tablet form, but the https://poppiefdrx156342.blogolize.com/glp-1-transdermal-delivery-systems-vs-tablets-is-right-for-the-patient-80108292